Type 1 Diabetes, ACTH Deficiency, and Hypothyroidism Simultaneously Induced by Nivolumab Therapy in a Patient with Gastric Cancer: A Case Report

Nivolumab, a fully human IgG4 immune checkpoint inhibitor (ICI) antibody, has been approved for a variety of cancers. Several endocrine-associated immune-related adverse events have been reported, but the incidence rate is relatively low. This is a case of a patient with gastric cancer who underwent...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Case Rep Oncol
Main Authors: Marshall, Shoko, Kizuki, Aki, Kitaoji, Tadashi, Imada, Hiroshi, Kato, Hayato, Hosoda, Mana, Ishikawa, Motonao, Sakura, Hiroshi
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2020
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7590777/
https://ncbi.nlm.nih.gov/pubmed/33173483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000510044
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados